Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ismael Rodriguez

8PUBLICATIONS

24CO-AUTHORS

Cheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Characterisation of biological macromolecules

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 27, 2024

Correction: Reyes Romero et al. Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. <i>Molecules</i> 2022, <i>27</i>, 8282.

Atilio Reyes Romero, Katarzyna Kubica, Radoslaw Kitel

|Jan 17, 2024

Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for <i>m</i>-Terphenyl Derivatives.

Ewa Surmiak, Julia Ząber, Jacek Plewka

|Jul 14, 2023

Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors.

Marta A Ważyńska, Roberto Butera, Marta Requesens

|Dec 11, 2022

Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein.

Atilio Reyes Romero, Katarzyna Kubica, Radoslaw Kitel

|Sep 08, 2022

Exploring the Surface of the Ectodomain of the PD-L1 Immune Checkpoint with Small-Molecule Fragments.

Radoslaw Kitel, Ismael Rodríguez, Xabier Del Corte

|Jun 10, 2022

Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction.

Shabnam Shaabani, Louis Gadina, Ewa Surmiak

Pageof 2

Frequent Collaborators

8 joint publications

Katarzyna Magiera-Mularz

6 joint publications

Tad Holak

5 joint publications

Ewa Surmiak

4 joint publications

Bogdan Musielak

4 joint publications

Jacek Plewka

3 joint publications

Justyna Kocik-Krol

3 joint publications

Lukasz Skalniak

2 joint publications

Dominik Sala

2 joint publications

Damian Muszak

2 joint publications

Alexander Dömling

Frequent Collaborators

8 joint publications

Katarzyna Magiera-Mularz

6 joint publications

Tad Holak

5 joint publications

Ewa Surmiak

4 joint publications

Bogdan Musielak

Top Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

See more related videos

Top Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

See more related videos